- 1、本文档共20页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
FDA工艺分析技术
Can Pharmaceutical Industry
Ignore PAT?
Matt Safi
Eurotherm Life Science group
October 2005
Agenda
• What is wrong with Pharmaceutical
Manufacturing today
• Is PAT the solution?
• Can Pharmaceutical industry ignore PAT?
Pharmaceutical Manufacturing
Today
What is Wrong today?
• Pressure on prices
• Low utilization 30 - 40 % on average
• Excessive amounts of product non-conformances
• Long lead-times due to stage and final product testing
• Capital and labor intensive
• High operating costs
• High inventories and excessive warehouse capacity
Typical Pharmaceutical Process life Cycle
20 Days
Final Film
Blend Coating
Granulation Step
Raw Chemical
Processing Blend 1 Compress Packaging
Material weighing
QC1 QC2 QC3
•Particle Size •Description
•API
•Load •ID
10 Days •Assay 15 Days
•Impurity
•Dissolution
W hat is wrong today?
• Most processes are fixed with variable materials,
resulting in variable quality of product.
• Most processes are not well understood.
• Existing procedural approach has created a “climate of
fear” stifling innovation .
文档评论(0)